KEYTRUDA 25 mg/mL concentrate for solution for infusion
PAM-UMCG-002
Phase 2 small_molecule active
Quick answer
KEYTRUDA 25 mg/mL concentrate for solution for infusion for Mismatch repair deficient endometrial cancer / uterine cancer is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Mismatch repair deficient endometrial cancer / uterine cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active